Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

Phase 1 Unknown 20 enrolled Shenzhen Hornetcorn Bio-technology Company, LTD Fifth Affiliated Hospital of Guangzhou Medical University · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for cerebral hemorrhage sequela.

Timeline

Start: 2015-03
Primary completion: 2016-12
Completion: 2017-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	human umbilical cord mesenchymal stem cells	Cell therapy	2e+07 cells	Intravenous

Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

Summary

Timeline

Drugs

Indications